ArticleClinical and experimental pediatrics2026

Tocilizumab as a key therapeutic option in high-risk pediatric acute necrotizing encephalopathy.

Jon Soo KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.